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Purpose: In a diagnostic exome sequencing study (the North
Carolina Clinical Genomic Evaluation by Next-Generation Exome
Sequencing project, NCGENES), we investigated adult patients’
intentions to request six categories of secondary findings (SFs) with
low or no medical actionability and correlates of their intentions.
Methods: At enrollment, eligible participants (n = 152) com-
pleted measures assessing their sociodemographic, clinical, and
literacy-related characteristics. Prior to and during an in-person
diagnostic result disclosure visit, they received education about
categories of SFs they could request. Immediately after receiving
education at the visit, participants completed measures of intention
to learn SFs, interest in each category, and anticipated regret for
learning and not learning each category.
Results: Seventy-eight percent of participants intended to learn at
least some SFs. Logistic regressions examined their intention to
learn any or all of these findings (versus none) and interest in each
of the six individual categories (yes/no). Results revealed little
association between intentions and sociodemographic, clinical, or
literacy-related factors. Across outcomes, participants who antici-
pated regret for learning SFs reported weaker intention to learn
them (odds ratios (ORs) from 0.47 to 0.71), and participants who
anticipated regret for not learning these findings reported stronger
intention to learn them (OR 1.61–2.22).
Conclusion: Intentions to request SFs with low or no medical
actionability may be strongly influenced by participants’ desire to
avoid regret.
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INTRODUCTION
Increasing use of genome and exome sequencing has
prompted debate about disclosing secondary findings (SFs)
—that is, information unrelated to the indication for
sequencing but potentially relevant to individuals’ health.1
Published recommendations2–4 reflect a general consensus
that medically actionable SFs (i.e., variants that reach
consensus-determined thresholds of clinical validity and
clinical utility) should be routinely offered. However, current
recommendations do not adequately address disclosure of SFs
that have clinical validity but lower medical actionability.
These SFs may be valued by people for their personal utility,
offering information they judge to be useful in the future.5
Understanding people’s preferences for learning SFs with
lower medical actionability, and factors associated with these
preferences, will inform recommendations, policy, and
development of educational and counseling approaches to
support informed decision making.
Evidence across various populations suggests that most
people initially express interest in all possible SFs—even those
with lower medical actionability. This response is observed
both when patients are offered this information6–10 and when
they are considering a hypothetical question of whether they
would want it if it were available.11–13 People often
demonstrate different levels of interest in different types of
SFs,6–8,12–14 suggesting that some features of SFs are
distinguished at least by some people.
Researchers have sought to identify correlates of preferences
for learning SFs of various types. Sociodemographic char-
acteristics often have null or weak associations with
preferences for learning SFs,10,15,16 as do individual-level
clinical characteristics such as prior genetic testing, role as a
patient or patient’s guardian, or patient diagnoses.8,10,15 Other
research has examined psychological correlates. One study of
advanced cancer patients’ preferences for learning SFs from
somatic and germ-line sequencing10 found that patients with
more positive attitudes about genetic testing had a higher
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confidence in their ability to make a good decision or handle
the consequences of their decision)22 could be incorporated
into a shared decision-making process.
We also investigated factors that may influence participants’
intentions, focusing on factors that could be pragmatically
evaluated in clinical settings: sociodemographic factors,
individual-level clinical factors, literacy-related factors that
may affect patients’ understanding of and comfort with
making decisions about complex genetic information, and
anticipated regret for learning and not learning the secondary
information. Anticipated regret and similar emotionally-
focused factors are increasingly incorporated into health
decision-making research to enrich evidence that previously
focused on cognition and rational decision processes.23
Evidence suggests that people are often highly motivated to
reduce uncertainty and to avoid feared and/or unpleasant
outcomes.23 The aim of this investigation was to guide
recommendations and strategies for offering and disclosing
results from a potentially vast and heterogeneous set of SFs
with lower medical actionability.
MATERIALS AND METHODS
Participants
Adult and pediatric patients with health conditions suspicious
for a monogenic etiology were referred by clinicians at the
University of North Carolina Hospitals (Chapel Hill, NC),
Moses Cone Memorial Hospital (Greensboro, NC), and
Vidant Medical Systems (Greenville, NC). All had exome
sequencing and received diagnostic results and, if identified,
medically actionable SFs.3 Adult patient participants who
were able to provide informed consent and who did not have
a medically actionable SF were randomized into either a
group that had the option to request SFs with lower medical
actionability (decision arm) or one that did not have this
option (control arm). The present study included only those
randomized to the decision group (n = 152 as of January
2016). Thus, participants were cognitively intact adults who
had not received medically actionable SFs and who were
randomized to have the option to learn SFs with lower
medical actionability.
Categories of secondary findings
SFs with lower medical actionability were grouped into six
categories based on the expert consensus of genetics
professionals on the study team:24 (i) single-nucleotide
polymorphisms associated with change in risk for a variety
of multifactorial diseases, (ii) pharmacogenomic variants, (iii)
variants that identified carrier status for recessive disorders,
(iv) APOE variants associated with risk for Alzheimer disease,
(v) variants associated with Mendelian diseases for which no
effective presymptomatic intervention exists, and (vi) variants
associated with Mendelian diseases that manifest with a
severe, progressive neurodegenerative course and that cannot
be prevented or effectively treated. These categories were used
for in-person and printed patient education (see Table 1).
preference for learning both somatic and germ-line findings. 
This study investigated SFs with clear medical actionability, 
but also a very limited domain of SFs with lower medical 
actionability in a population with unique concerns because of 
their advanced disease. It is unclear whether these findings 
will generalize to broader patient populations or to a broader 
set of SFs with lower medical actionability.
Other relevant evidence comes from a large-scale pilot 
study investigating use of genomic sequencing to identify 
genetic risk for heart disease.17 Participants were older adult 
community resident volunteers; nearly all were white and 
well-educated and had a high income. The investigators 
examined participants’ intentions to learn medically action-
able SFs and other SFs including carrier status and gene 
variants with uncertain meaning for health. Generally speak-
ing, participants with positive attitudes toward SFs and 
stronger perceptions that others thought they should learn 
them had stronger intentions to learn SFs.7 Participants with 
higher dispositional optimism and greater perceived risk for 
common diseases also had stronger intentions to learn SFs.18 
Conversely, participants who believed they were more likely 
to be emotionally devastated or unable to cope if they learned 
threatening information15 or perceived the findings to be 
more ambiguous (i.e., relatively low in interpretability, 
trustworthiness, and accuracy)19 had a weaker intention to 
learn SFs. Effects of perceived ambiguity were modified by 
dispositional factors (e.g., medical ambiguity aversion). These 
findings reveal associations between psychological factors and 
intentions to learn SFs, but apply to a limited domain of SFs 
with lower medical actionability. The study’s low racial/ethnic 
and socioeconomic diversity also raises questions about 
generalization to more diverse samples.
Overview of the present study
Data for the present study were from the North Carolina 
Clinical Genomic Evaluation by Next-Generation Exome 
Sequencing (NCGENES) project, which is investigating 
integration of diagnostic exome sequencing and return of 
SFs into clinical practice.20 Participants were child and adult 
patients enrolled to undergo diagnostic exome sequencing to 
determine the etiology of a suspected genetic disorder. 
Additionally, intellectually competent adult patient partici-
pants who did not receive medically actionable SFs were 
entered into a randomized study of decision making regarding 
six categories of SFs with lower medical actionability. The 
present study investigated intentions to request these SFs in 
participants randomized to have the option to request them. 
Intentions reliably predict substantial variance in subsequent 
behavior,21 revealing an inclination to make a particular 
decision. Thus, they provide a theory-based foundation for 
understanding and supporting informed decision making. For 
instance, antecedents of intentions such as patients’ attitudes 
about learning SFs (i.e., beliefs about the value and 
consequences of learning them), perceived social norms 
concerning this decision (i.e., beliefs about others’ approval 
of their decision, or others’ decisions), and self-efficacy (i.e.,
Procedures
Staff recruited patients to NCGENES by phone and scheduled
an enrollment visit. These potential participants completed a
mailed intake questionnaire and brought it to their enroll-
ment visit, at which they met with a board-certified genetic
counselor to provide informed consent and blood samples for
sequencing. Randomization to the decision or control group
occurred after participants’ diagnostic results were ready, 6–
12 months later. Participants were informed of their group
assignment in a letter confirming their appointment for an in-
person return of results visit. For decision arm participants,
this mailing included a brochure describing “non-medically
actionable” SFs, the six categories and examples of conditions
in each, and potential benefits and harms of learning SFs from
each category. These descriptions were designed by clinicians
and researchers on the study team to present a balanced
discussion of pros and cons, and the brochure included a
values clarification exercise to promote informed decision
making; participants were invited to record their reasons for
learning and for not learning each category, then summarize
these reasons in a chart they could bring to their return of
results visit. At this visit, participants first learned their
diagnostic results in a meeting with a geneticist, usually
accompanied by a certified genetic counselor. The clinicians
then shifted to educating them about SFs, reiterating and
expanding on information in the brochure. Participants were
informed that they had to call the study coordinator to
request SFs, initiating analysis of the requested categories (i.e.,
their SFs had not already been analyzed), and that when their
results were ready, staff would call them to schedule an
appointment to disclose requested SFs by phone or in person,
depending on categories requested. Prior to leaving the clinic
appointment, participants completed a post–return of results
interview and questionnaire. All procedures were approved by
the institutional review boards of the University of North
Carolina, Chapel Hill, and the Vidant Medical System.
Measures
Sociodemographic variables (patient sex, age, race, ethnicity,
educational attainment, annual household income, marital
status, and health insurance status) were obtained from health
records or were self-reported in the intake questionnaire.
Clinical variables other than type of diagnostic result were
measured in the intake questionnaire. Physical functioning
was assessed with the self-report Karnofsky Performance
Status scale,25,26 which includes eight categories from “I am
Table 1 Categories of secondary findings and summary of information provided in NCGENES patient-education brochure
Category Description from brochure Examples provided How patients learn
findings after call to
request them
A. Single-nucleotide polymorphisms (SNPs)
associated with increased risk for a variety
of common diseases
“Variants, called SNPs (pronounced
“snips”), that may slightly affect your
chance for developing common conditions





B. Pharmacogenomic variants “Variants that affect how your body




C. Carrier status for recessive conditions “Variants in genes that do not usually affect
your health but that increase the risk for
health problems in your children and others
in future generations.”
 Cystic fibrosis
 Sickle cell anemia
 One in-person visit
D. Risk for Alzheimer disease associated
with APOE variants
“Variants in a gene called APOE that affect
your risk, as compared to the average
person, of getting the common form of
Alzheimer’s disease.”
 One in-person visit
E. Risk for rare Mendelian diseases for
which no effective presymptomatic
intervention exists
“Rare variants in genes that directly cause
you to have an increased risk for a genetic
disease that cannot be prevented, but that





 One in-person visit
F. Risk for very rare, highly penetrant
Mendelian diseases that cannot be
prevented or effectively treated and
manifest with a progressive
neurodegenerative course
“Very rare variants in genes that directly
cause severe and progressive diseases of the
brain and nervous system that cannot be
prevented and that have no effective
treatments after symptoms develop.”
 Amyotrophic lateral
sclerosis
 Two in-person visits
NCGENES, North Carolina Clinical Genomic Evaluation by Next-Generation Exome Sequencing project.
they would decide to learn any of them using the following
scale: 1 = you definitely will not, 2 = you probably will not,
3 = you’re not sure, 4 = you probably will, and 5 = you
definitely will. Participants answering 4 or 5 were asked which
categories they would be interested in learning (scored
1 = interested and 0 = not interested for each category).
Interviewers emphasized that their decision was not final.
Analyses
We conducted descriptive analyses and evaluated the
psychometric properties of all measures. Missing income data
were replaced using the median income for North Carolina
from 2014 (which approximated our sample’s median
income).31 Missing dichotomous general health literacy data
were replaced using participants’ educational attainment;
those with less than a ninth-grade education were entered as
having low literacy. Remaining missing data were minimal
and were replaced with mean and mode imputation, as
appropriate. The dichotomous primary outcome was inten-
tion to learn some or all SFs versus no SFs. Interest in learning
each of the six categories of SFs were secondary outcomes. We
determined which variables to enter into logistic regression
analyses predicting these outcomes by examining correlations
between the outcomes and sociodemographic, clinical,
literacy, and anticipated regret variables. These variables were
entered into a model for a particular outcome if they were
correlated with the outcome at Po 0.10.
RESULTS
Descriptive statistics are shown in Table 2. Correlations
among study variables are shown in Table 3.
Participant characteristics
About three-quarters of participants were women and nearly
one-quarter identified as Hispanic and/or nonwhite. Average
age was 47 years. Fewer than half had a 4-year college degree
or graduate education. Participants’mean income fell between
$45,000 and $59,999. Their clinical characteristics and literacy
varied considerably.
Seventy-six percent of participants intended to learn some
or all categories of SFs, including 38% who intended to learn
all six categories and 38% who intended to learn some but not
all categories. More than half were interested in learning
category A (61%), B (63%), C (61%), D (61%), and E (55%).
Slightly fewer were interested in category F (49%). For
participants who intended to learn some but not all categories,
combinations of categories they were interested in learning
were highly heterogeneous, with no predominant pattern.
Participants’ average anticipated regret scores corresponded
to anticipating that they would regret learning these findings
between “a little bit” and “somewhat” and anticipating that
they would regret not learning these findings between
“somewhat” and “quite a bit.” The moderate negative
correlation between these scores suggested that it is possible
to anticipate regret from both learning and not learning these
findings. A paired-samples t-test indicated that participants
severely disabled and I require hospitalization and continuous 
nursing care” to “I am able to carry on normal activity or do 
work, and I have no physical complaints or problems” (coded 
1–8, with higher scores indicating better functioning). Prior 
genetic testing was assessed with the question: “Have you ever 
had a genetic test? (it’s usually a blood test)” (yes/no). Types 
of diagnostic result were positive (findings revealed an 
explanation for the health concern), negative (findings did 
not reveal an explanation for the health concern), or uncertain 
(findings could possibly explain the health concern). A 
dichotomous variable for each type indicated whether it had 
been found for each participant (yes/no).
Literacy variables
General health literacy was assessed in person at enrollment 
using the 66-item Rapid Estimate of Adult Literacy 
Measure.27 A literacy score was created by summing the 
number of words pronounced correctly. Participants were 
categorized as low literacy (score of 0–60; less than ninth-
grade reading level) or high literacy (score of 61–66; ninth-
grade reading level or higher),28 making use of recommended 
cutoffs but collapsing across categories indicating low literacy 
because of the small proportion of these patients. Objective 
numeracy was assessed in the intake questionnaire with a 
validated measure that presented three math problems 
involving proportions, fractions, and percentages.29 Correct 
responses were summed to create a numeracy score. 
Secondary findings knowledge was assessed in the post–
return of results questionnaire with 12 items created for this 
study assessing knowledge of facts covered in our brochure 
and in-person counseling (e.g., “Learning this type of 
information will usually tell you for certain whether or not 
you will get a health problem in the future”). Participants 
marked each item “true,” “false,” or “not sure/don’t know.” 
We summed correct responses to create a knowledge score, 
with “not sure/don’t know” responses considered incorrect 
(Cronbach’s alpha = 0.69).
Anticipated regret was assessed in the post–return of results 
interview with a measure30 adapted to evaluate anticipated 
regret for not learning and for learning each of the six 
categories of SFs (12 items total). The interviewer described a 
category and asked: “Imagine that you got a health problem 
that you believe this information could have prepared you for 
or helped you avoid. How much would you regret not 
choosing to learn this information?” or “Imagine that you 
chose to get this information and you found out something 
about your health you did not want to know. How much 
would you regret choosing to learn this information?” The 
order of these questions was randomized across participants. 
Responses ranged from 1 = not at all to 5 = very much and 
were averaged to create scores indicating anticipated regret for 
not learning SFs and for learning SFs (alphas = 0.91 and 0.90, 
respectively).
Intention to learn SFs was assessed in the post–return of 
results interview. Participants were instructed to consider the 
categories of SFs together and to report how likely it was that
anticipated greater regret for not learning SFs than for
learning them (Po 0.001).
Intention to learn secondary findings from some or all
(versus no) categories
When potential predictors (Table 3) were entered into a
logistic regression to evaluate their independent effects
controlling for other variables in the model (Table 4),
findings indicated that having higher general health literacy,
higher numeracy, and higher anticipated regret for not
learning SFs were associated with greater likelihood of
intending to learn some or all SFs. Anticipated regret for
learning SFs was associated with lower likelihood of intending
to learn SFs. Secondary findings knowledge was not associated
with this outcome.
Interest in learning secondary findings from each category
These logistic regression analyses are described below and
summarized in Table 5. Across all categories of SFs,
anticipated regret for not learning the category was
associated with greater interest in learning these findings
(all Po 0.001) and anticipated regret for learning the
category was independently associated with lower interest in
learning them (P from 0.036 to o0.001). With a few
Variable n (%) Mean (SD) Range
Age at enrollment 47.2 (14.2) 17–77
Female sex 108 (71.1)
Non-Hispanic white race/ethnicity 115 (75.7)
Educational attainment
Less than 4-year college degree 87 (57.2)
4-year college degree or higher 63 (41.4)
Missing 2 (1.3)




Not married 100 (65.8)
Insurance status
Insured 134 (88.2)
Not insured 16 (10.5)
Missing 2 (1.3)




No or not sure 71 (46.7)
Missing 3 (2.0)
Type of diagnostic result
Positive result 19 (12.5)
Negative results 97 (63.8)
Uncertain results 36 (23.7)
General health literacy 63.20 (5.24) 24 to 66
≥9th-grade reading level 123 (80.9)
o9th-grade reading level 21 (13.8)
Missing 8 (5.3)
Objective numeracy 1.5 (1.2) 0 to 3
Secondary findings knowledge 8.5 (2.4) 1 to 12
Missing 6 (3.9)
Anticipated regret for learning secondary findings 2.3 (1.1) 1 to 5
Missing 2 (1.3)
Anticipated regret for not learning secondary findings 3.6 (2.4) 1 to 5
Missing 2 (1.3)
aOn a scale from 1 to 8, with 8 indicating the best physical functioning.
























































































































































































































































































































































































































































































































































































































































































































































































































































































































exceptions, other factors did not help explain participants’
interest in learning these categories. For category C, greater
numeracy was associated with greater interest in learning the
findings (P = 0.026). For category E, women were less likely
than men to intend to learn these findings (P = 0.01). Having
had a prior genetic test was associated with greater interest in
learning category E (P = 0.02).
DISCUSSION
In a sample of adult patients undergoing diagnostic exome
sequencing, we investigated participants’ intentions to learn
some or all SFs with lower medical actionability and a broad
set of correlates of their intentions. Approximately three out
of four participants intended to learn at least some of these
SFs. Participants were more likely to report this intention if
they had higher general health literacy and greater numeracy,
if they more strongly anticipated that they would regret not
learning this information, and if they anticipated that they
were relatively unlikely to regret learning it. We found similar
results for each of the six categories of SFs, with few
exceptions. Thus, forming an intention to learn SFs with
lower medical actionability was largely motivated by a desire
to avoid a future negative emotional state—regret23—rather
than membership in sociodemographic or clinical subgroups.
Participants anticipated greater regret for not learning than
for learning the SFs we studied, consistent with research in
other populations32 and possibly helping to explain why most
participants’ initial response was to intend to learn at least
some of their SFs. Their interest in learning these findings is
consistent with other studies using different populations and
research methods.4,6–13 The effect size of anticipated regret for
not learning SFs (“anticipated inaction regret”) was large,
similar to large effects for anticipated inaction regret found in
a meta-analysis of the broad body of research on health-
related intentions (e.g., for behaviors such as vaccination,
cancer screening, and safe sex practices),32 whereas the effect
size of anticipated regret for learning SFs (“anticipated action
regret”) was small compared with effect sizes for anticipated
action regret in that same meta-analysis. Thus, effects of
anticipating regret for learning SFs with lower medical
actionability were weak compared with the larger literature.
Despite in-person and printed education describing both
potential harms and limited clinical utility, patients appeared
to perceive few downsides in learning this information.
Converging evidence shows that some people view SFs as
valuable for protecting their own and their family’s health,
that they perceive SFs as potentially useful in the future, and
that they feel that having knowledge is empowering.33,34 Thus,
our participants’ intentions to learn this information was
consistent with the idea that they perceived it as having
personal utility, despite education regarding its lack of
tangible medical actionability and the limits of genomic
sequencing and current knowledge of genetic causes of
disease.35,36 Personal utility may be an important type of
attitude affecting behavioral intentions. According to the
theory of planned behavior and similar theories, it may
therefore play a causal role in determining behavioral
intentions and subsequent behavior.22
The two forms of anticipated regret we investigated
compete with each other: one motivates patients to consider
learning their SFs whereas the other motivates the opposite
choice. Given their moderate association, some participants
anticipated regret for both getting and not getting this
information, leaving them ambivalent about this decision.
Ambivalence can affect decision making in complex ways.37
There may also be practical and other barriers to following
through on intentions to learn SFs. Forthcoming analyses of
NCGENES participants’ decisions will clarify how intentions
to request SFs of lower medical actionability translate to
actual requests for these SFs. An important goal will be to
consider the role of various potential barriers to action and
other factors that may influence the link between intentions
and behavior. Although behavioral intentions reliably predict
a substantial proportion of variance in subsequent behavior,
understanding the factors that influence the strength of this
association22 in the context of SFs will provide useful insight
into circumstances under which patients’ initial intentions
will and will not translate into actual requests.
The relatively small percentage (38%) of our participants
who intended to learn all of their SFs contrasts with larger
percentages in other studies.6,13,14 One explanation for this
discrepancy may be our tiered consent: we educated
participants about SFs and asked them to make a decision
about learning the six categories only after they had received
their diagnostic results, thereby separating the desire for a
diagnostic result from a desire for SFs. Participants also had a
relatively open-ended time frame to make decisions, elim-
inating pressure to risk losing their chance. Our approach
Table 4 Logistic regression analysis predicting intention to learn some or all secondary findings with low or no medical
actionability (versus none) (N = 152)
Variable B SE OR 95% CI P
High general health literacy (≥9th-grade reading level) 1.89 0.68 6.61 1.76, 24.85 0.005
Numeracy 0.46 0.23 1.59 1.01, 2.49 0.044
Secondary findings knowledge −0.09 0.12 0.91 0.72, 1.15 0.431
Anticipated regret for learning secondary findings −0.75 0.23 0.47 0.3, 0.74 0.001
Anticipated regret for not learning secondary findings 0.8 0.22 2.22 1.44, 3.42 o0.001





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































of educational and counseling interventions. Furthermore,
our sample included a diverse set of diagnoses and socio-
demographic diversity, enhancing the generalizability of our
results. We examined intentions in an actual decision,
avoiding response biases that may affect hypothetical
decisions. We also investigated a broad set of potential SFs,
allowing us to evaluate intentions and correlates of those
intentions across categories with different clinical and
psychosocial risk profiles. Finally, we studied a broader set
of potential correlates of participants’ intention to learn SFs
than has been investigated in the past, focusing on those that
could be evaluated by a clinician to help guide patient
education and counseling.
In conclusion, our findings suggest avenues for future
research and development of patient education and counsel-
ing interventions, given that behavioral intentions predict
subsequent health behavior38 and greater anticipated regret
may strengthen the link between intention and behavior.39
Genetic counselors are trained to prompt patients to consider
and probe for anticipated regret,40 and other clinicians could
learn this technique. These findings may also guide
recommendations for returning SFs in a way that balances
patients’ desire to learn SFs with practicality, costs, and
burden on the health-care system and research budgets. To
the extent their desire is prompted by the goal of avoiding
negative emotional outcomes, it is worthwhile to consider
ways to balance this desire with information that improves
their ability to make informed decisions.
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contrasts with more typical current clinical practice in which 
these decisions are made at the time of consent for sequencing 
(e.g., due to laboratory consent forms and protocols) limiting 
both the time patients have to consider their decision and 
opportunity to provide them with education and counseling 
about their options. Finally, we clearly communicated that 
analysis of SFs would only be performed if participants 
specifically requested them, emphasizing that we were not in 
possession of knowledge they were not yet privy to. Although 
it is not clear whether patients understand what a laboratory 
may or may not know about their SFs before any request is 
made, these procedures may have increased the likelihood 
that our participants would weigh the value of available SFs 
and balance their desire to get them with competing goals 
(e.g., managing the implications of their diagnostic results).
There were several study limitations. First, we did not 
evaluate the influence of study clinicians who counseled 
participants, nor did we standardize or script their presenta-
tion of information about SFs. Although the clinicians may 
have varied somewhat in their presentation, we believe that 
any such variation did not influence our findings. The 
clinicians reiterated and expanded upon information in the 
study brochure, which they helped develop and which offered 
a balanced discussion of potential harms and limited benefits 
of each category. Also, most sessions were led by both a 
geneticist and a certified genetic counselor with formal 
training in avoiding being directive. However, further 
research on patient–provider communications and the effects 
of variation on anticipated regret in clinical settings is 
warranted, particularly because variation in “real world” 
settings would be important for designing clinical support. 
Second, our measure of SF knowledge was developed for this 
study and thus not validated. Its internal consistency (0.69) 
fell just under the accepted rule-of-thumb cutoff for good 
internal consistency (0.70), suggesting the need for research 
using a refined measure. Third, we investigated participants’ 
intention to request SFs rather than their actual requests. 
Analyses investigating actual requests and the link between 
intentions and subsequent behavior are underway—a critical 
research question in light of evidence that in some areas of 
genomics intentions do not have a strong association with 
subsequent behaviors.21 Yet, investigation of behavioral 
intentions is important in its own right, particularly because 
we assessed intentions at a time that offers an ideal 
opportunity to intervene to ensure informed decision making 
prior to actual requests for SFs. Finally, pediatric patients, 
adult patients with cognitive impairment, and adult patients 
who received medically actionable SFs were not eligible for 
randomization. Thus, our findings apply to cognitively intact 
adult patients. Parents of pediatric or cognitively impaired 
adult patients may have different perspectives.
The study also had notable strengths. Our approaches to 
categorizing SFs, educating participants about them, and 
allowing participants to request them were designed to reflect 
a clinically realistic, reasonable, and ethical protocol that 
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